Roche lays the foundation for the diagnostics production of the future in Germany

Investment of more than 600 million euros in a high-tech production center - Roche's largest single investment in Germany to date

29-Nov-2024 - Roche lays the foundation stone for one of Europe's most modern production centers for high-quality diagnostic input materials on the campus of its biotechnology center in Penzberg, Upper Bavaria. The company is investing more than 600 million euros - Roche's largest single investment in Germany. ...

New nanosensors make diagnostic procedures more sensitive

The nanosensors can be used to track reactions with invisible light, saving materials and time

16-Feb-2024 - The Fraunhofer Institute for Microelectronic Circuits and Systems IMS and Ruhr University Bochum, Germany, have developed a process that enables a new form of signal amplification for diagnostic tests. Through the advanced use of luminescent single walled carbon nanotubes in bioanalytics, test ...

Start-up competition m4 Award announces winners

2.5 million euros for five research teams from Bavaria

26-Oct-2023 - The five winners of this year's m4 Award pre-founding competition have been announced. Each winning team will receive 500,000 euros for their project to solve urgent medical challenges. The award was announced by BioM together with the Bavarian State Ministry of Economic Affairs, Regional ...

Diagnostics, meet CRISPR

15-Apr-2020 - A new diagnostic test to quickly and easily monitor kidney transplant patients for infection and rejection relies on a simple urine sample and a powerful partner: the gene-editing technology CRISPR. Michael Kaminski, who developed it, leads a new Emmy Noether Group at the MDC & Charité. The ...

Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over

01-Apr-2020 - Researchers at the German Red Cross Blood Donor Service in Frankfurt headed by Professor Erhard Seifried, and the Institute for Medical Virology at the University Hospital Frankfurt at Goethe University headed by Professor Sandra Ciesek succeeded in developing a procedure that makes it possible ...

Researchers develop first diagnostic test for novel coronavirus in China

17-Jan-2020 - Researchers from the German Center for Infection Research (DZIF) at Charité - Universitätsmedizin Berlin have developed a new laboratory assay to detect the novel Chinese coronavirus. The assay protocol has now been published by WHO as a guideline for diagnostic detection. The new assay enables ...

How reliable is diagnostic testing for Zika?

05-Mar-2018 - Globally, Brazil has been the hardest hit by the current Zika outbreak. Almost all cases of Zika-associated malformations in newborns have been reported from this country. DZIF scientists from the Charité – Universitätsmedizin Berlin have shown that molecular diagnostic tests for the Zika virus ...

Nanoparticles help with malaria diagnosis

New rapid test in development

23-Nov-2017 - Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases. An early diagnosis is vital for the timely and right kind of therapy. There are five different types of parasites at the origin of the ...

Innovationsstarter Fonds Hamburg and High-Tech Gründerfonds are investing together in KSK Diagnostics GmbH

Development of molecular point-of-care diagnostic tests

26-Apr-2017 - KSK Diagnostics GmbH uses its isothermal amplification technology, KDx rITA®, for the development of molecular point-of-care tests to identify pathogens and antimicrobial resistance within 30 minutes. This significantly reduces the time before therapy is started. A financing round has now been ...

Myriad acquires Sividon Diagnostics

Strengthens oncology portfolio with breast cancer prognostic test

02-Jun-2016 - Myriad Genetics announced that it has acquired Sividon Diagnostics, a leading breast cancer prognostic company, for €35 million upfront with the potential for €15 million in additional performance-based milestones. The transaction closed on May 31, 2016. Myriad expects the deal to be neutral to ...